Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABAL.L Regulatory News (ABAL)

  • There is currently no data for ABAL

Director/PDMR - Share Subscription

3 Jul 2009 14:21

RNS Number : 1112V
Imaginatik PLC
03 July 2009
 



3 July 2009

Imaginatik plc

("Imaginatik" or the "Company")

Share Subscription

Further to the achievement of certain financial objectives in the year ended 31 March 2009 and in lieu of the grant of a cash bonus, each of Shawn Taylor, Chief Financial Officer, Andrew Wainwright, Chief Technology Officer and Geoff Carrs, Executive Vice President, has agreed to subscribe for 53,147, 44,289 and 53,147 new ordinary shares of 0.0625p each respectively in Imaginatik at a price of 6.33p per share, being the average closing mid-market price of the Company's shares between 17 June and 19 June 2009. Two other senior executives have also agreed to subscribe for an aggregate of 97,210 new ordinary shares on the same terms.

Application will be made to the London Stock Exchange for the admission to trading on AIM of in aggregate 247,793 new ordinary shares of 0.0625p each (the "New Ordinary Shares"). It is expected that admission of the New Ordinary Shares will become effective on 9 July 2009 ("Admission"). Following Admission, the holdings of each of the above Directors will be as follows: -

Director

Shareholding following Admission

% of enlarged shareholding following Admission

Shawn Taylor

1,378,858

1.04

Andrew Wainwright

1,425,752

1.07

Geoff Carss

204,429

0.15

For further information please contact:

Imaginatik plc

Tel: +44 (0)20 7917 2975 

Mark Turrell, CEO / Shawn Taylor, CFO

Arbuthnot Securities Limited

Tel: +44 (0)20 7012 2000

Tom Griffiths

Investor relations and UK media

ICIS

Tel: +44 (0)20 7651 8688

Tom Moriarty / Caroline Evans Jones

About Imaginatik

Imaginatik is a leading provider of web-based enterprise collaboration software. Imaginatik's core software, Idea Central, is designed to help companies focus on idea generation towards strategic business objectives, and to share, develop and review those ideas across the organisation. Some of the world's largest organisations such as Merck, Dow, Chevron, General Electric and Cargill use Imaginatik's software, consulting and leading-edge research to enable their best-of-breed innovation, cost-reduction and process improvement activities.

Having been named as a World Economic Forum Technology Pioneer and a finalist for the IBM Lotus Awards in the Best Industry Solution category, Imaginatik's software and consulting services have helped clients discover significant sources of additional revenue, as well as tangible cost savings. Imaginatik is also committed to developing strategic solutions in the field of innovation, working with academic institutions such as the Hult Business School in Boston, and the Cass School of Business, London, as well as leading practitioners of corporate innovation.

For further information please visit www.imaginatik.com 

.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSUUUBGMUPBGWW
Date   Source Headline
9th Jun 201710:54 amRNSProposed Placing
27th Apr 20177:00 amRNSChange of Registered Office
25th Apr 20177:00 amRNSTrading Update
24th Apr 20178:16 amRNSHolding(s) in Company
27th Feb 201710:35 amRNSHolding(s) in Company
14th Dec 20169:31 amRNSHolding(s) in Company
9th Dec 201611:47 amRNSHolding(s) in Company
6th Dec 20167:00 amRNSHalf-year Report
25th Nov 20169:56 amRNSHolding(s) in Company
24th Nov 20167:00 amRNSTrading Update and Notice of Results
13th Sep 20162:29 pmRNSResult of AGM
13th Sep 20167:00 amRNSGrant of Options
17th Aug 20167:00 amRNSFinal Results
10th Aug 20163:21 pmRNSHolding(s) in Company
21st Jul 20164:46 pmRNSHolding(s) in Company
28th Jun 201612:12 pmRNSHolding(s) in Company
27th Jun 201611:45 amRNSHolding(s) in Company
24th Jun 20167:00 amRNSResult of Open Offer and Total Voting Rights
16th Jun 201610:35 amRNSHolding(s) in Company
13th Jun 201611:20 amRNSResult of General Meeting
25th May 20167:00 amRNSFundraising
17th May 201612:26 pmRNSFunding Update
17th May 201610:51 amRNSPress Speculation
29th Apr 20169:09 amRNSHolding(s) in Company
28th Apr 201610:54 amRNSHolding(s) in Company
27th Apr 20169:04 amRNSHolding(s) in Company
13th Apr 20161:36 pmRNSHolding(s) in Company
12th Apr 201610:18 amRNSHolding(s) in Company
6th Apr 20164:51 pmRNSHolding(s) in Company
6th Apr 20161:23 pmRNSPress Speculation
9th Mar 20167:00 amRNSTrading Update
26th Jan 201610:03 amRNSHolding(s) in Company
21st Jan 20162:51 pmRNSHolding(s) in Company
5th Jan 20167:00 amRNSDirector Loan
17th Dec 20158:20 amRNSHolding(s) in Company
15th Dec 20157:00 amRNSGrant of Options
10th Dec 20157:00 amRNSHalf Yearly Report
13th Nov 20153:35 pmRNSWarrant Exercise
9th Nov 20153:57 pmRNSTrading update
6th Nov 20154:13 pmRNSHolding(s) in Company
23rd Sep 20153:07 pmRNSResult of AGM
16th Sep 20157:00 amRNSDirector Loan
14th Sep 20155:33 pmRNSHolding(s) in Company
1st Sep 20154:34 pmRNSNotice of AGM
1st Sep 20152:23 pmRNSHolding(s) in Company
24th Aug 20157:00 amRNSHolding(s) in Company
10th Aug 20152:20 pmRNSHolding(s) in Company
6th Aug 20151:41 pmRNSHolding(s) in Company
3rd Aug 201512:05 pmRNSHolding(s) in Company
30th Jul 20151:16 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.